These findings will give us clues as to the origin of different forms of Aβ plaques in AD brains, and further provide a novel therapeutic target for AD through suppression of SP maturation, for example, by inhibiting the interaction between CLAC and Aβ fibrils. Here, COL25A1 is linked to Alzheimer disease.